274 related articles for article (PubMed ID: 29292958)
21. Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease.
Nagy AI; Venkateshvaran A; Merkely B; Lund LH; Manouras A
Eur J Heart Fail; 2017 Jan; 19(1):88-97. PubMed ID: 27748008
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure.
Lundgren J; Rådegran G
Acta Physiol (Oxf); 2014 Jun; 211(2):314-33. PubMed ID: 24703457
[TBL] [Abstract][Full Text] [Related]
23. Significance of Pulmonary Vascular Resistance and Diastolic Pressure Gradient on the New Definition of Combined Post-Capillary Pulmonary Hypertension.
Sugimoto K; Yoshihisa A; Nakazato K; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Ishida T; Takeishi Y
Int Heart J; 2020; 61(2):301-307. PubMed ID: 32224602
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary Hypertension Due to Left Ventricular Cardiomyopathy: Is it the Result or Cause of Disease Progression?
Adusumalli S; Mazurek JA
Curr Heart Fail Rep; 2017 Dec; 14(6):507-513. PubMed ID: 29063280
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications.
Guazzi M; Labate V
Curr Heart Fail Rep; 2016 Dec; 13(6):281-294. PubMed ID: 27858232
[TBL] [Abstract][Full Text] [Related]
26. Treatment of advanced group 2 PH.
Barnett CF; De Marco T
Prog Cardiovasc Dis; 2016; 59(1):78-86. PubMed ID: 27417251
[TBL] [Abstract][Full Text] [Related]
27. Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH).
Dayeh NR; Ledoux J; Dupuis J
Prog Cardiovasc Dis; 2016; 59(1):11-21. PubMed ID: 27195752
[TBL] [Abstract][Full Text] [Related]
28. The Biological Bases of Group 2 Pulmonary Hypertension.
Fernández AI; Yotti R; González-Mansilla A; Mombiela T; Gutiérrez-Ibanes E; Pérez Del Villar C; Navas-Tejedor P; Chazo C; Martínez-Legazpi P; Fernández-Avilés F; Bermejo J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771195
[TBL] [Abstract][Full Text] [Related]
29. When Pulmonary Hypertension Complicates Heart Failure.
Marra AM; Benjamin N; Cittadini A; Bossone E; Grünig E
Heart Fail Clin; 2020 Jan; 16(1):53-60. PubMed ID: 31735315
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary Hypertension Due to Left Heart Disease: an Update.
Aras MA; Psotka MA; De Marco T
Curr Cardiol Rep; 2019 May; 21(7):62. PubMed ID: 31134443
[TBL] [Abstract][Full Text] [Related]
31. Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction.
Dixon DD; Trivedi A; Shah SJ
Heart Fail Rev; 2016 May; 21(3):285-97. PubMed ID: 26714826
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary hypertension associated with left heart disease.
Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
[TBL] [Abstract][Full Text] [Related]
33. Management of pulmonary hypertension in left heart disease.
Schmeisser A; Schroetter H; Braun-Dulleaus RC
Ther Adv Cardiovasc Dis; 2013 Jun; 7(3):131-51. PubMed ID: 23592742
[TBL] [Abstract][Full Text] [Related]
34. Management of Pulmonary Hypertension in Left Heart Disease.
Macera F; Vachiéry JL
Methodist Debakey Cardiovasc J; 2021; 17(2):115-123. PubMed ID: 34326931
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S
J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary artery diastolic pressure gradient as an indicator of severity of illness in patients with pulmonary hypertension related to left-sided heart disease.
Howard C; Rangajhavala K; Safdar Z
Ther Adv Respir Dis; 2015 Apr; 9(2):35-41. PubMed ID: 25721948
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of Pulmonary Hypertension in Left Heart Disease.
Guha A; Amione-Guerra J; Park MH
Prog Cardiovasc Dis; 2016; 59(1):3-10. PubMed ID: 27402130
[TBL] [Abstract][Full Text] [Related]
38. Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
van de Veerdonk MC; Roosma L; Trip P; Gopalan D; Vonk Noordegraaf A; Dorfmüller P; Nossent EJ
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38417969
[TBL] [Abstract][Full Text] [Related]
39. [Pulmonary hypertension associated with left heart disease (group 2)].
Schmidt KH; Bikou O; Blindt R; Bruch L; Felgendreher R; Hohenforst-Schmidt W; Holt S; Ladage D; Pfeuffer-Jovic E; Rieth A; Schmeisser A; Schnitzler K; Stadler S; Steringer-Mascherbauer R; Yogeswaran A; Kuebler WM
Pneumologie; 2023 Nov; 77(11):926-936. PubMed ID: 37963482
[TBL] [Abstract][Full Text] [Related]
40. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
Michaels AD; Chatterjee K; De Marco T
J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
